Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy

Archives of General Psychiatry

Volumn 55, Issue 6, 1998, Pages 524-530

  Neumeister, Alexander ^a,b   Turner, Erick H ^a   Matthews, Jefferey R ^a   Postolache, Teodor T ^a   Barnett, Ronald L ^a   Rauh, Manfred ^c   Vetticad, Rina G ^a   Kasper, Siegfried ^b   Rosenthal, Norman E ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; CATECHOLAMINE; DIPHENHYDRAMINE; HOMOVANILLIC ACID; METIROSINE; PLACEBO; TRYPTOPHAN;

ADULT; AFFECTIVE NEUROSIS; AMINO ACID BLOOD LEVEL; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; PHOTOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REMISSION; SEASONAL VARIATION;

ADULT; ALPHA-METHYLTYROSINE; AMBULATORY CARE; AMINO ACIDS; CATECHOLAMINES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HOMOVANILLIC ACID; HUMANS; MALE; METHOXYHYDROXYPHENYLGLYCOL; MIDDLE AGED; NOREPINEPHRINE; PHOTOTHERAPY; PLACEBOS; SEASONAL AFFECTIVE DISORDER; SEROTONIN; TRYPTOPHAN;

EID: 0031776485     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.55.6.524     Document Type: Article

References (55)

1. Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, Mueller PS, Newsome DA, Wehr TA. Seasonal affective disorder: a description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry. 1984; 41:72-80.
2. Terman M, Terman JS, Quitkin FM, McGrath PJ, Stewart JW, Rafferty B. Light therapy for seasonal affective disorder: a review of efficacy. Neuropsychopharmacology. 1989;2:1-22.
3. Rosenthal NE, Sack DA, Skwerer RG, Jacobsen FM, Wehr TA. Phototherapy for seasonal affective disorder. J Biol Rhythms. 1988;3:101-120.
4. Carlsson A, Svennerholm L, Winblad B. Seasonal and circadian monoamine variations in human brains examined post-mortem. Acta Psychiatr Scand. 1980;61 (suppl 280)75-83.
5. Wirz-Justice A, Richter R. Seasonality in biochemical determinations: a source of variance and a clue to the temporal incidence of affective illness. Psychiatr Res. 1979;1:53-60.
6. Brewerton TD. Seasonal variation of serotonin function in humans: research and clinical implications. Ann Clin Psychiatry. 1989;1:153-164.
7. Arora RC, Meltzer HY. Seasonal variation of imipramine binding in the blood platelets of normal controls and depressed patients. Biol Psychiatry. 1988;23:217-226.
8. Brewerton TD, Berrettini W, Nurnberger J, Linnoila M. An analysis of seasonal fluctuations of CSF monoamines and neuropeptides in normal controls: findings with 5-HIAA and HVA. Psychiatr Res. 1988;23:257-265.
9. Maes M, Scharpé S, Verherk R, D'Hondt P, Peeters D, Cosyns P, Thompson P, DeMeyer F, Wauters A, Neels H. Seasonal variation in plasma L-tryptophan availability in healthy volunteers: relationships to violent suicide occurrence. Arch Gen Psychiatry. 1995;52:937-946.
10. Jacobsen FM, Mueller EA, Rosenthal NE, Rogers S, Hill JL, Murphy DL. Behavioral responses to intravenous meta-chlorophenylpiperazine in patients with seasonal affective disorder and control subjects before and after phototherapy. Psychiatry Res. 1994;52:181-197.
11. Schwartz PJ, Murphy DL, Wehr TA, Garcia-Borreguero D, Oren DA, Moul DE, Ozaki N, Snelbaker AJ, Rosenthal NE. Effects of m-CPP infusions in patients with seasonal affective disorder and healthy controls: diurnal responses and nocturnal regulatory mechanisms. Arch Gen Psychiatry. 1997;54:375-385.
12. Joseph-Vanderpool JR, Jacobsen FM, Murphy DL, Hill JL, Rosenthal NE. Seasonal variation in behavioral responses to m-CPP in patients with seasonal affective disorder and controls. Biol Psychiatry. 1993;33:496-504.
13. Garcia-Borreguero D, Jacobsen FM, Murphy DL, Joseph-Vanderpool JR, Chiara A, Rosenthal NE. Hormonal responses to the administration of m-chlorophenylpiperazine in patients with seasonal affective disorder and controls. Biol Psychiatry. 1995;37:740-749.
14. Yatham LN, Lam RW, Zis AP. Growth hormone response to sumatriptan (5-HT1D agonist) challenge in seasonal affective disorder: effects of light therapy. Biol Psychiatry. 1997;42:24-29.
15. Rosenthal NE, Genhart MJ, Caballero B, Jacobsen FM, Skwerer RG, Coursey RD, Rogers S, Spring BJ. Psychobiological effects of carbohydrate- and protein-rich meals in patients with seasonal affective disorder and normal controls. Biol Psychiatry. 1989;25:1029-1040.
16. Fernstrom JD. Carbohydrate ingestion and brain serotonin synthesis: relevance to a putative control loop for regulating carbohydrate ingestion, and effects of aspartame consumption. Appetite. 1988;11(suppl 1):35-41.
17. O'Rourke D, Wurtman JJ, Wurtman RJ, Chebli R, Gleason R. Treatment of seasonal affective disorder with d-fenfluramine. J Clin Psychiatry. 1989;50:343-347.
18. Blashko CA. A double-blind, placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorders. Eur Neuropsychopharmacol. 1995;5:258. Abstract 6.1.
19. Lam RW, Gorman CP, Michalon M, Steiner M, Levitt AJ, Corral MR, Watson GD, Morehouse RL, Tam W, Joffe RT. A multi-centre, placebo-controlled study of fluoxetine in seasonal affective disorder. Am J Psychiatry. 1995;152:1765-1770.
20. Rudorfer MV, Skwerer RG, Rosenthal NE. Biogenic amines in seasonal affective disorder: effects of light therapy. Psychiatry Res. 1993;46:19-28.
21. Anderson JL, Vasile RG, Mooney JJ, Bloomingdale KL, Samson JA, Schildkraut JJ. Changes in norepinephrine output following light therapy for fall/winter seasonal depression. Biol Psychiatry. 1992;32:700-704.
22. Jacobsen FM, Sack DA, Wehr TA, Rogers S, Rosenthal NE. Neuroendocrine response to 5-hydroxytryptophan in seasonal affective disorder. Arch Gen Psychiatry. 1987;44:1086-1091.
23. Depue RA, Arbisi PA, Krauss S, Iacono WG, Leon A, Muir R, Allen J. Seasonal independence of low prolactin concentration and high spontaneous eye blink rates in unipolar and bipolar II seasonal affective disorder. Arch Gen Psychiatry. 1990; 47:356-364.
24. Oren DA, Levendosky AA, Kasper S, Duncan CC, Rosenthal NE. Circadian profiles of cortisol, prolactin, and thyrotropin in seasonal affective disorder. Biol Psychiatry. 1996;39:157-170.
25. Barbato G, Moul DE, Schwartz P, Rosenthal NE, Oren DA. Spontaneous eye blink rate in winter seasonal affective disorder. Psychiatry Res. 1993;47:79-85.
26. Arbisi P, Depue RA, Spoont MR, Leon A, Ainsworth B. Thermoregulatory response in seasonal affective disorder. Psychiatry Res. 1989;28:323-334.
27. Oren DA, Moul DE, Schwartz P, Wehr TA, Rosenthal NE. A controlled trial of levodopa plus carbidopa in the treatment of winter seasonal affective disorder: a test of the dopamine hypothesis. J Clin Psychopharmacol. 1994;14:196-200.
28. Heninger GR, Delgado PL, Charney DS. The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry. 1996;29:2-11.
29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
30. Williams JB, Link MJ, Rosenthal NE, Terman M. Structured Interview Guide for the Hamilton Depression Rating Scale, Seasonal Affective Disorder Version (SIGH-SAD). New York, NY: New York Psychiatric Institute; 1988.
31. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR. Serotonin function and the mechanism of antidepressant action: reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry. 1990;47:411-418.
32. Bartko JJ, Carpenter WT. On the methods and theory of reliability. J Nerv Ment Dis. 1976;163:307-317.
33. Anderson GM, Young JG, Cohen DJ, Schlicht KR, Patel N. Liquid-chromatographic determination of serotonin and tryptophan in whole blood and plasma. Clin Chem. 1981;27:775-776.
34. Bacopulos NG, Redmond DE, Roth RH. Serotonin and dopamine metabolites in brain regions and cerebrospinal fluid of a primate species: effects of ketamine and fluphenazine. J Neurochem. 1979;32:1215-1218.
35. Maas JW, Hattox SE, Landis DH. The determination of a brain arteriovenous difference for 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG). Brain Res. 1976; 118:167-173.
36. Gessa GL, Biggio G, Fadda F, Corsini GV, Tagliamonte A. Effect of oral administration of tryptophan-free amino acid mixtures on serum tryptophan, brain tryptophan and serotonin metabolism. J Neurochem. 1974;22:869-870.
37. Moja EA, Cipolla P, Castoda D, Tofanetti O. Dose-responsive decrease in plasma tryptophan and brain tryptophan and serotonin after tryptophan-free amino acid mixtures in rats. Life Sci. 1989;44:971-976.
38. Young SN, Ervin FR, Pihl RO. Biochemical aspects of tryptophan depletion in primates. Psychopharmacology. 1989;98:508-511.
39. Nishizawa S, Benkelfat C, Young SN, Leyton M, Mzengeza S, deMontigny C, Blier P, Diksic M. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A. 1997;94:5308-5313.
40. Stancampiano R, Melis F, Sarais L, Cocco S, Cugusi C, Fadda F. Acute administration of a tryptophan-free amino acid mixture decreases 5-HT release in rat hippocampus in vivo. Am J Physiol. 1997;272:R991-R994.
41. Tagliamonte A, Biggio G, Vargiu L, Gessa GL. Free tryptophan in serum controls brain tryptophan level and serotonin synthesis. Life Sci. 1973;12:277-287.
42. Maes M, Jacobs MP, Suy E, Vandewoude M, Minner B, Raus J. Effects of dexamethasone on the availability of L-tryptophan and on the insulin and FFA concentrations in unipolar depressed patients. Biol Psychiatry. 1990;27:854-862.
43. Baldessarini RJ. Treatment of depression by altering monoamine metabolism: precursors and metabolic inhibitors. Psychopharmacol Bull. 1984;2:224-239.
44. Miller HL, Delgado PL, Salomon RM, Berrnan R, Krystal JH, Heninger GR, Charney DS. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression. Arch Gen Psychiatry. 1996;53:117-128.
45. Miller HL, Delgado PL, Salomon RM, Heninger GR, Charney DS. Effects of amethyl-para-tyrosine (AMPT) in drug-free depressed patients. Neuropsychopharmacol. 1996;14:151-157.
46. Bunney WE, Brodie KH, Murphy DL, Goodwin FK. Studies of alpha-methyl-paratyrosine. L-dopa, and L-tryptophan in depression and mania. Am J Psychiatry. 1971;7:872-880.
47. Widerlöv E, Lewander T. Inhibition of the in vivo biosynthesis and changes of catecholamine levels in rat brain after α-methyl-p-tyrosine: time and doseresponse relationships. Naunyn Schmiedebergs Arch Pharmacol. 1978;304:111-123.
48. Lam RW, Zis AP, Grewal A, Delgado PL, Charney DS, Krystal JH. Effects of tryptophan depletion in patients with seasonal affective disorder in remission after light therapy. Arch Gen Psychiatty. 1996;53:41-44.
49. Neumeister A, Rieder-Praschak N, Heßelmann B, Rao M-L, Glück J, Kasper S. Effects of tryptophan depletion on drug-free patients with seasonal affective disorder during a stable response to bright light therapy. Arch Gen Psychiatry. 1997; 54:133-138.
50. Neumeister A, Praschak-Rieder N, Heßelmann B, Vitouch O, Rauh M, Barocka A, Kasper S. Rapid tryptophan depletion in drug-free depressed patients with seasonal affective disorder. Am J Psychiatry. 1997;154:1153-1155.
51. Neumeister, A, Praschak-Rieder N, Heßelmann B, Vitouch O, Rauh M, Barocka A, Kasper S. Effects of tryptophan depletion in fully remitted patients with seasonal affective disorder during summer. Psychol Med. 1998;28:257-264.
52. McCann UD, Thorne D, Hall M, Popp K, Avery W, Sing H, Thomas M, Belenky G. The effects of L-dihydroxyphenylalanine on alertness and mood in α-methylpara-tyrosine-treated healthy humans. Neuropsychopharmacology. 1995;13:41-52.
53. Haddjeri N, Blier P, deMontigny C. Effects of the a2-adrenoreceptor antagonist mirtazapine on the 5-hydroxytryptamine system in the rat brain. J Pharmacol Exp Ther. 1996;277:861-871.
54. Mongeau R, Blier P, deMontigny C. In vivo electrophysiological evidence fortonic activation by endogenous noradrenaline on a2-adrenergic heteroreceptors of 5-hydroxytryptamine terminals in the rat hippocampus. Naunyn Schmiedebergs Arch Pharmacol. 1993;347:266-272.
55. Baraban JM, Aghajanian GK. Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology. 1980; 19:355-363.